MILLENNIUM MANAGEMENT LLC

Position in ATNM — Actinium Pharmaceuticals, Inc.

CIK 1273087 NEW YORK, NY

Position in ATNM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$504,288

-$57,489 QoQ

Shares Held

514,580

-8.9% QoQ

Ownership

1.64%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 47 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. ATNM ranks #269 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	468,410	$232,673,299
2	INSM	INSMED Inc	2,048,005	$218,358,293
3	APGE	Apogee Therapeutics, Inc.	1,491,404	$197,954,052
4	JAZZ	Jazz Pharmaceuticals plc	763,880	$184,072,163
5	ONC	BeOne Medicines Ltd.	543,323	$154,830,755
6	AXSM	Axsome Therapeutics, Inc.	556,088	$136,113,659
7	BMRN	Biomarin Pharmaceutical Inc	2,071,816	$118,549,311
8	REGN	Regeneron Pharmaceuticals, Inc.	165,120	$102,958,924

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$504,288	514,580	-8.9%	Shares	Sole	2026-08-14
2026-03-31	$561,777	564,600	-6.2%	Shares	Sole	2026-05-15
2025-12-31	$818,176	601,600	-3.7%	Shares	Sole	2026-02-17
2025-09-30	$999,515	624,697	-5.8%	Shares	Sole	2025-11-14
2025-06-30	$928,576	663,269	+464.7%	Shares	Sole	2025-08-14
2024-12-31	$147,992	117,454	-26.6%	Shares	Sole	2025-02-14
2024-09-30	$301,031	160,123	+661.1%	Shares	Sole	2024-11-14
2024-06-30	$155,681	21,038	-68.8%	Shares	Sole	2024-08-14
2024-03-31	$527,828	67,411	-70.8%	Shares	Sole	2024-05-15
2023-03-31	$2,184,575	231,172	+329.8%	Shares	Sole	2023-05-15
2022-12-31	$572,757	53,780	+9.4%	Shares	Sole	2023-02-14
2022-09-30	$362,712	49,148	+48.3%	Shares	Sole	2022-11-14
2022-06-30	$159,403	33,140	-39.8%	Shares	Sole	2022-08-15
2020-12-31	$429,156	55,020	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.